Announcements Trials
Browse Landscape

Phase

Phase 3 19Phase 2 14Phase 1 8Phase 1/2 7Phase NA 3Phase 2/3 2Phase 4 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Other neoplasm 1Gynecologic 1

Conditions

Leukemia, Promyelocytic, Acute 3Leukemia 1

Interventions

Cyclophosphamide 34Cytarabine 33Exercise 26Blood Specimen Collection 24venetoclax 23fludarabine phosphate 22Busulfan 22fludarabine 18Methotrexate 18Methods 18Cyclosporine 18Peripheral Blood Stem Cell Transplantation 17Filgrastim 17Antilymphocyte Serum 17Standard of Care 16Whole-Body Irradiation 15Granulocyte Colony-Stimulating Factor 15Educational Status 15Early Intervention, Educational 15Palliative Care 14Melphalan 14Daunorubicin 14Mycophenolic Acid 13Azacitidine 13Practice Guidelines as Topic 12Etoposide 12Dexamethasone 12Radiotherapy 11Interviews as Topic 10Vincristine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Tretinoin × Other hematologic neoplasm × Clear all
NCT07187505 2025-09-23

Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia

Anhui Medical University

Phase NA Active not recruiting
28 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT05832320 2024-05-10

Optimum Induction Therapy of Low-risk APL

Peking University People's Hospital

Phase NA Unknown
74 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT01064557 2020-10-14

"AIDA" Protocol (LAP 0493)

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase NA Unknown
1,068 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡